Table I.
Demographics and HIV-related characteristics of N = 120 COPA participants
| Characteristic | All Mean(sd ) N(%) | Patient Active/Provider Active (n = 30) | Patient Active/Provider Inactive (n = 31) | Patient Inactive/Provider Active (n = 30) | Patient Inactive/Provider Inactive (n = 29) | Fa, p Chi- square ,p |
|---|---|---|---|---|---|---|
|
| ||||||
| Gender | 3.35, .341 | |||||
| Male | 61(51%) | 11(37%) | 18(58%) | 16(53%) | 16(55%) | |
| Female | 59(49%) | 19(63%) | 13(42%) | 14(47%) | 13(45%) | |
|
| ||||||
| Age | 40.0(8.6) | 39.7(8.6) | 38.6(7.2) | 41.6(9.9) | 39.9(8.7) | 0.64, .589 |
|
| ||||||
| Education level | 3.27, .352 | |||||
| High school or greater | 61(52%) | 12(40%) | 19(63%) | 15(52%) | 15(52%) | |
| Did not finish high school | 57(48%) | 18(60%) | 11(37%) | 14(48%) | 14(48%) | |
|
| ||||||
| Employment status (n = 118) | 0.44, .932 | |||||
| Employed | 76(63%) | 19(63%) | 20(65%) | 20(67%) | 17(59%) | |
| Unemployed | 44(37%) | 11(37%) | 11(35%) | 10(33%) | 12(41%) | |
|
| ||||||
| Monthly income in Argentine Pesos (n = 106) (ARS) 1USD = ~100 ARS |
4472
ARS(3238) |
3687 ARS (2091) | 3983 ARS (3011) | 6068 ARS (4357) | 3568 ARS (2645) | 3.53, .018 |
|
| ||||||
| Marital status | 4.01, .675 | |||||
| Married | 24(20%) | 5(17%) | 9(29%) | 5(17%) | 5(17%) | |
| Not married | 72(60%) | 20(66%) | 18(58%) | 18(60%) | 16(55%) | |
| Other (e.g., divorced, widowed) | 24(20%) | 5(17%) | 4(13%) | 7(23%) | 8(28%) | |
|
| ||||||
| Years since HIV diagnosis (n = 115) | 11.3(6.1) | 10.7(6.4) | 11.3(6.1) | 10.4(6.0) | 13.0(5.9) | 0.96, .413 |
|
| ||||||
| Years since ART initiation (n = 109) | 9.8(5.8) | 9.2(5.9) | 9.8(5.5) | 9.8(5.7) | 10.5(6.5) | 0.21, .892 |
|
| ||||||
| Has a current partner | 0.46, .927 | |||||
| Yes | 74(62%) | 13(43%) | 11(35%) | 11(37%) | 11(38%) | |
| No | 46(38%) | 17(57%) | 20(65%) | 19(63%) | 18(62%) | |
|
| ||||||
| Partner HIV status (n = 74 with a current partner) | 0.99, .803 | |||||
| Positive | 26(35%) | 5 (29%) | 6(30%) | 8(41%) | 7(39%) | |
| Negative/Unknown | 48(65%) | 12(71%) | 14(70%) | 11(58%) | 11(61%) | |
|
| ||||||
| ART Regimen (n = 118 with data available) | Fisher’ s exact test p = .857 | |||||
| NRTIs + PI | 61(52%) | 16(55%) | 16(52%) | 16(55%) | 13(45%) | |
| NRTIs + NNRTI | 43(36%) | 8(28%) | 12(38%) | 10(34%) | 13(45%) | |
| Otherb | 14(12%) | 5(17%) | 3(10%) | 3(10%) | 3(10%) | |
a
F statistic and p-value refer to an ANOVA test for any difference of means
b
Other ART regimens included combinations of several families including NRTI, NNRTI, PI, integrase inhibitors (raltegravir), fusion inhibitor (T-20), or CCR5 inhibitor (maraviroc) selected according the past ART history and the genotypic results
Note: Bold indicates a statistically significant difference between clinics.
Note: N varies due to instances of missing data on questionnaire items.